Search PubMed⌕ Search

PubMed · 10740887

Implementation of a stereotactic radiotherapy system.

Abstract

The tests carried out on a recently-installed stereotactic radiotherapy system capable of fully frameless stereotaxy are outlined. The two principle investigations carried out on the planning system were a dosimetry test, and a test to verify the accuracy of localisation from CT examination through to patient treatment. The method employed in frameless relocation for fractionated stereotactic radiotherapy--position detection using stereoscopic infra-red cameras and a set of fiducials attached to a bite-block--was tested for reproducibility. The results of these tests suggest a mean accuracy in treatment localisation of 1.23 mm (maximum 2.72 mm) for single fraction techniques, and 1.77 mm (maximum 4.53 mm) for treatments involving repeated (frameless) localisation. The implications of these accuracies for treatment with single, multiple-fraction and multi-isocentre techniques are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M A Ebert, A M Perry, C S Harper. 1999. Implementation of a stereotactic radiotherapy system.. https://pubmed.ncbi.nlm.nih.gov/10740887/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Postshunt encephalopathy in liver transplanted children with portal vein thrombosis.

BACKGROUND: Surgical portosystemic shunting has been reported to alleviate successfully portal hypertension in liver transplanted recipients with portal vein thrombosis. METHODS: We report two liver transplanted children with portal vein thrombosis who developed post-shunt acute encephalopathy. In one child, a mesocaval H-type shunt was created surgically because of bleeding related to Roux-en-Y loop varices at 3 months posttransplantation; in the other, a large spontaneous splenorenal shunt was discovered at the time of diagnosis of portal vein thrombosis on day 34 posttransplantation and was preserved. RESULTS: Post-shunt encephalopathy developed 6 months and 2.7 years after transplantation, causing death in one child. CONCLUSIONS: This report illustrates the risk and the possible dismal outcome of post-shunt encephalopathy in liver transplanted children. Therapeutic procedures other than portosystemic shunting that will restore an hepatopetal portal flow to the liver graft should be considered in liver-transplanted children with portal vein thrombosis.

Brain Diseases↗